The Impact of AmniSure
Accurately diagnosing premature rupture of fetal membranes (PROM) is of critical importance for a clinician. An accurate diagnosis of ROM at any term during pregnancy is crucial to timely and proper treatment and to determine the need for prompt hospitalization. Failure to identify patients with ROM can result in a delay or inability to implement salutary obstetric measures. Conversely, a false positive diagnosis of ROM can lead to inappropriate or untimely interventions such as hospitalization or induction of labor.
The AmniSure ROM Test is a rapid, non-invasive immunoassay that aids clinicians with the diagnosis of ROM in pregnant women with signs and symptoms suggestive of the condition. According to published data it is ~99% accurate.